E. Canalis, J. Pash, and S. Varghese, Skeletal growth factors, Crit Rev Eukaryot Gene Expr, vol.3, pp.155-166, 1993.

T. L. Mccarthy, M. Centrella, and E. Canalis, Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures, Endocrinology, vol.124, pp.301-309, 1989.

E. Canalis, S. Rydziel, A. M. Delany, S. Varghese, and J. J. Jeffrey, Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures, Endocrinology, vol.136, pp.1348-1354, 1995.

S. Rydziel, A. M. Delany, and E. Canalis, Insulin-like growth factor I inhibits the transcription of collagenase 3 in osteoblast cultures, J Cell Biochem, vol.67, pp.176-183, 1997.

J. Holly, Physiology of the IGF system, Novartis Found Symp, vol.262, pp.265-268, 2004.

R. T. Kurmasheva and P. J. Houghton, IGF-I mediated survival pathways in normal and malignant cells, Biochim Biophys Acta, vol.1766, pp.1-22, 2006.

P. A. Hill, J. J. Reynolds, and M. C. Meikle, Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function, Endocrinology, vol.136, pp.124-131, 1995.

Y. Wang, S. Nishida, H. Z. Elalieh, R. K. Long, and B. P. Halloran, Role of IGF-I signaling in regulating osteoclastogenesis, J Bone Miner Res, vol.21, pp.1350-1358, 2006.

C. Price, B. C. Herman, T. Lufkin, H. M. Goldman, and K. J. Jepsen, Genetic variation in bone growth patterns defines adult mouse bone fragility, J Bone Miner Res, vol.20, pp.1983-1991, 2005.

K. J. Jepsen, B. Hu, S. M. Tommasini, H. W. Courtland, and C. Price, Phenotypic integration of skeletal traits during growth buffers genetic variants affecting the slenderness of femora in inbred mouse strains, Mamm Genome, vol.20, pp.21-33, 2009.

L. Shoba, M. R. An, S. J. Frank, W. L. Lowe, and J. , Developmental regulation of insulin-like growth factor-I and growth hormone receptor gene expression, Mol Cell Endocrinol, vol.152, pp.125-136, 1999.

J. P. Liu, J. Baker, A. S. Perkins, E. J. Robertson, and A. Efstratiadis, Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r), Cell, vol.75, pp.59-72, 1993.

C. Richman, S. Kutilek, N. Miyakoshi, A. K. Srivastava, and W. G. Beamer, Postnatal and pubertal skeletal changes contribute predominantly to the differences in peak bone density between C3H/HeJ and C57BL/6J mice, J Bone Miner Res, vol.16, pp.386-397, 2001.

J. E. Wergedal, M. H. Sheng, C. L. Ackert-bicknell, W. G. Beamer, and D. J. Baylink, Genetic variation in femur extrinsic strength in 29 different inbred strains of mice is dependent on variations in femur cross-sectional geometry and bone density, Bone, vol.36, pp.111-122, 2005.

S. Yakar, C. J. Rosen, W. G. Beamer, C. L. Ackert-bicknell, and Y. Wu, Circulating levels of IGF-1 directly regulate bone growth and density, J Clin Invest, vol.110, pp.771-781, 2002.

Y. Wu, P. B. , H. Sun, W. Mejia, R. Novosyadlyy et al., Shoshana Yakar (In Press) IGF-1 regulates the liver microenvironment in obese mice and promotes liver metastasis, Cancer Research

S. Yakar, M. L. Bouxsein, E. Canalis, H. Sun, and V. Glatt, The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone, J Endocrinol, vol.189, pp.289-299, 2006.

S. Yakar, J. Setser, H. Zhao, B. Stannard, and M. Haluzik, Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice, J Clin Invest, vol.113, pp.96-105, 2004.

A. M. Parfitt, M. K. Drezner, F. H. Glorieux, J. A. Kanis, and H. Malluche, Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee, J Bone Miner Res, vol.2, pp.595-610, 1987.

E. Corpas, S. M. Harman, and M. R. Blackman, Human growth hormone and human aging, Endocr Rev, vol.14, pp.20-39, 1993.

H. Maheshwari, L. Sharma, and G. Baumann, Decline of plasma growth hormone binding protein in old age, J Clin Endocrinol Metab, vol.81, pp.995-997, 1996.

R. Yuan, S. W. Tsaih, S. B. Petkova, M. De-evsikova, C. Xing et al., Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels, Aging Cell, vol.8, pp.277-287, 2009.

S. Mohan, C. Richman, R. Guo, Y. Amaar, and L. R. Donahue, Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms, Endocrinology, vol.144, pp.929-936, 2003.

S. Yakar, C. J. Rosen, M. L. Bouxsein, H. Sun, and W. Mejia, Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism, FASEB J, vol.23, pp.709-719, 2009.

J. Jiang, A. C. Lichtler, G. A. Gronowicz, D. J. Adams, and S. H. Clark, Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling, 2006.

M. Zhang, S. Xuan, M. L. Bouxsein, V. Stechow, D. Akeno et al., Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization, J Biol Chem, vol.277, pp.44005-44012, 2002.

C. Malet, A. Gompel, P. Spritzer, N. Bricout, and H. Yaneva, Tamoxifen and hydroxytamoxifen isomers versus estradiol effects on normal human breast cells in culture, Cancer Res, vol.48, pp.7193-7199, 1988.

A. Resch, E. Biber, M. Seifert, and H. Resch, Evidence that tamoxifen preserves bone density in late postmenopausal women with breast cancer, Acta Oncol, vol.37, pp.661-664, 1998.

L. M. Starnes, C. M. Downey, S. K. Boyd, and F. R. Jirik, Increased bone mass in male and female mice following tamoxifen administration, Genesis, vol.45, pp.229-235, 2007.

R. T. Turner, G. K. Wakley, K. S. Hannon, and N. H. Bell, Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats, Endocrinology, vol.122, pp.1146-1150, 1988.

S. Yakar, E. Canalis, H. Sun, W. Mejia, and Y. Kawashima, , p.1, 2009.

, Determines Skeletal Strength by Regulating Subperiosteal Expansion and Trait Interactions, Journal of Bone and Mineral Research, vol.24, pp.1481-1492

S. Yakar, E. Canalis, H. Sun, W. Mejia, and Y. Kawashima, Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions, J Bone Miner Res, vol.24, pp.1481-1492, 2009.

C. J. Rosen, H. P. Dimai, D. Vereault, L. R. Donahue, and W. G. Beamer, Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities, Bone, vol.21, pp.217-223, 1997.

P. Gillberg, H. Olofsson, H. Mallmin, W. F. Blum, and S. Ljunghall, Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men, Calcif Tissue Int, vol.70, pp.22-29, 2002.

J. A. Langlois, C. J. Rosen, M. Visser, M. T. Hannan, and T. Harris, Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study, J Clin Endocrinol Metab, vol.83, pp.4257-4262, 1998.

M. B. Patel, N. K. Arden, L. M. Masterson, D. I. Phillips, and R. Swaminathan, Investigating the role of the growth hormone-insulin-like growth factor (GH-IGF) axis as a determinant of male bone mineral density (BMD), Bone, vol.37, pp.833-841, 2005.

E. J. Rhee, K. W. Oh, W. Y. Lee, S. W. Kim, and E. S. Oh, Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men, J Bone Miner Metab, vol.22, pp.392-398, 2004.